US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

48.61

-0.6395-1.30%

Post-market: 48.42-0.1869-0.38%19:35 EDT

Volume:9K

Turnover:451.66K

Market Cap:46.18M

PE:- -

High:49.12

Open:49.12

Low:48.33

Close:49.25

52wk High:56.18

52wk Low:24.54

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.49

T/O Rate:0.98%

Dividend:0.66

Dividend Rate:1.35%

ROE:--

ROA:--

PB:1.04

PE(LYR):- -

Loading ...

Overview Company News Filings

Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

Nepal Flood Disaster Claims 469 Lives, 977 Missing; Government Confirms Glacial Collapse Triggered Catastrophic Flooding

NeuroThera Labs Hires European IR Firm to Expand Investor Reach

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

BNK Banking Corporation Plans FY26 Results and Strategy Briefing

BNK Bank Takes Goodwill Hit But Grows Margins and Loan Book in FY26

BNK Banking Corporation Swings to Loss as Revenue Declines and Dividends Remain Suspended

Glacial Melt Swells Rivers, Himalayan Floods Trigger Landslide on China-Nepal Border

Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug

Global Average Sea Surface Temperature Reaches Unprecedented High, Potentially Warmest Since the Last Interglacial Period

Savara announces presentations of Results from Phase 3 trial of Molgramostim

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY

TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BBC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":48.6069,"timestamp":1789761600000,"preClose":49.2464,"halted":0,"volume":9298,"hourTrading":{"tag":"盘后","latestPrice":48.42,"preClose":48.6069,"latestTime":"19:35 EDT","volume":14,"amount":681.289,"timestamp":1789774511202,"change":-0.1869,"changeRate":-0.003845,"amplitude":0},"delay":0,"changeRate":-0.012985720783651154,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Market Closed","change":-0.6395,"latestTime":"09-18 16:00:00 EDT","open":49.12,"high":49.12,"low":48.33,"amount":451662.734936,"amplitude":0.016042,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":49.2464,"sharesOutstanding":900004,"nav":49.294,"aum":46829269.03,"dividendRate":0.013482,"bidAskSpread":0.002154,"postHourTrading":{"tag":"盘后","latestPrice":48.42,"preClose":48.6069,"latestTime":"19:35 EDT","volume":14,"amount":681.289,"timestamp":1789774511202,"change":-0.1869,"changeRate":-0.003845,"amplitude":0},"volumeRatio":0.491749526871824,"impliedVol":0.2995,"impliedVolPercentile":0.247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.491749526871824,"shares":950000,"dividePrice":0.6553,"high":49.12,"amplitude":0.016042,"preClose":49.2464,"low":48.33,"week52Low":24.54,"pbRate":"1.04","week52High":56.18,"institutionHeld":0,"latestPrice":48.6069,"eps":0,"divideRate":0.013482,"volume":9298,"delay":0,"ttmEps":0,"open":49.12,"prevYearClose":38.56,"prevWeekClose":49.3848,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":49.3848,"twentyDayClose":53.8707,"sixtyDayClose":49.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664958418","title":"Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2664958418","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664958418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:00","pubTimestamp":1788321600,"startTime":"0","endTime":"0","summary":"The BBC offered 91 per cent less for the Glasgow Commonwealth Games than they paid for Birmingham in 2022 Commonwealth Games chiefs took flak for agreeing a broadcast deal with TNT Sports that put it behind a paywall for the first time in 72 years – but City AM can reveal the BBC offered less than 1m for the rights.The BBC’s bid of around 900,000 represented a 91 per cent decrease on the 10m the organisation paid for the rights to broadcast the 2022 Commonwealth Games in Birmingham.TNT Sports, owned by Warner Bros Discovery, ended up paying around 5m to become the competition’s official UK partner, showing all the action on its linear TV channel and streaming it on HBO Max. TNT Sports costs between 25.99 and 30.99 per month, while HBO Max is available for 4.99 per month.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855897","title":"Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855897?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"– Following productive FDA discussions, Upstream Bio will study 400 mg of verekitug administered every 12 weeks, versus placebo, in severe asthma and CRSwNP with one pivotal Phase 3 trial in each indi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353967/0/en/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-severe-asthma-and-crswnp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSH","TSDD","BBC","TSLO","TSII","09366","07766","TSLP","TSLT","TSLR","TSLS","TLA","TSL","TSLG","07366","TEST","TESC","TESL","TSLI","TSLW","TSLY","LABU","TSYY","ELOL","TSLZ","09766","TSLQ","PSIL","TSLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","JDOC","LNGR","IEIH","AGNG","BK4585","BK4552","IE00BFXG1179.USD","LU2237443382.USD","SYNB","IE0002270589.USD","BK4550","LU0251131958.USD","GSX","LU0868494617.USD","LU1868837136.USD","LU1668664300.SGD","LU2471134523.USD","LU2896262040.SGD","LTGO","FHLC","IE0004086264.USD","BK4516","IE0004091025.USD","BBC","LU1868836757.USD","LU2237443622.USD","LU0210536198.USD","IE00BSNM7G36.USD","LU2237443549.SGD","XT","LU1894683348.USD","LU0942090050.USD","LU1868836914.USD","LU2237438978.USD","BK4007","LU2237443895.HKD","DARP","LU0106831901.USD","LU0345770993.USD","BK4127","IBB","LU0096364046.USD","LU1868836591.USD","IE00B19Z3B42.SGD","LU2471134796.USD","BK4504","BBP","LU1144417596.USD","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009747","title":"AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663009747?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934678,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765646.SGD","AGNG","LU1496350171.SGD","LU1934455194.USD","GLAM","LU0942090050.USD","RXL","VHT","SG9999011175.SGD","IE00BLSP4239.USD","IE000SO60NU8.SGD","MEDX","LU1267930490.SGD","ABBV","PSIL","IE000BZT7R73.USD","BK4585","LU0985320562.USD","FTXH","PPH","TRUH","IE0000B7K699.USD","LU1244550494.USD","IE00B2B36J28.USD","LU1989772840.SGD","FHLC","LU0029864427.USD","LU0057025933.USD","XLV","LU2129689431.USD","LU2089283258.USD","LU0868494708.USD","LU1670627923.USD","IYH","IXJ","PJP","LU1496350502.SGD","BBC","BK4550","IE0002141913.USD","JDOC","LU1074936037.SGD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU0726765562.USD","LU2112291526.USD","IE00B42XCP33.USD","IE0004445239.USD","LU0795875169.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663547097","title":"BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2663547097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663547097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:15","pubTimestamp":1787933700,"startTime":"0","endTime":"0","summary":"BioNTech ($BNTX) shares declined as much as 10% on Friday after the company said it has ended a key Phase 2 trial for its mRNA colorectal cancer va...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4548","BK4551","BK4568","BK4535","BBC","BNTX","PSIL","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136125076","title":"Nepal Flood Disaster Claims 469 Lives, 977 Missing; Government Confirms Glacial Collapse Triggered Catastrophic Flooding","url":"https://stock-news.laohu8.com/highlight/detail?id=1136125076","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136125076?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:10","pubTimestamp":1787897453,"startTime":"0","endTime":"0","summary":"Nepal has been struck by a devastating flood disaster, with the death toll climbing to 469 and 977 people still unaccounted for. The catastrophic event has also impacted the tourism sector...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403754","title":"NeuroThera Labs Hires European IR Firm to Expand Investor Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403754?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:02","pubTimestamp":1787878968,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an announcement. NeuroThera Labs Inc., a clinical-stage biotech subsidiary of SciSparc Ltd. listed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-hires-european-ir-firm-to-expand-investor-reach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-hires-european-ir-firm-to-expand-investor-reach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","EPV","BBC","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084187","title":"Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084187?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848308,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-La...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU1061106388.HKD","LU2468319806.SGD","BIB","BK4599","IE0002141913.USD","AMGN","BK4534","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU2112291526.USD","LU0320765992.SGD","LU1023059063.AUD","IBBQ","LU0868494617.USD","LU0889565916.HKD","IBB","BK4585","IE0009355771.USD","BK4566","PJP","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BBH","LU1571399168.USD","TBXU","LU2242646821.SGD","LU1057294990.SGD","LU0109394709.USD","LU2242652126.USD","PBE","BK4139","IE00BJT1NW94.SGD","BK4533","BBC","LU0058720904.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662472330","title":"BNK Banking Corporation Plans FY26 Results and Strategy Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662472330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662472330?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:08","pubTimestamp":1787785731,"startTime":"0","endTime":"0","summary":"BNK Banking Corporation Limited ( ($AU:BBC) ) has provided an update. BNK Banking Corporation Limited, branded as “The Bank for Enterprising Austra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-plans-fy26-results-and-strategy-briefing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-plans-fy26-results-and-strategy-briefing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662572354","title":"BNK Bank Takes Goodwill Hit But Grows Margins and Loan Book in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662572354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662572354?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:08","pubTimestamp":1787785715,"startTime":"0","endTime":"0","summary":"BNK Banking Corporation Limited ( ($AU:BBC) ) has issued an announcement. BNK Banking Corporation Limited reported a statutory net loss of $3.7 mil...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-bank-takes-goodwill-hit-but-grows-margins-and-loan-book-in-fy26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-bank-takes-goodwill-hit-but-grows-margins-and-loan-book-in-fy26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662233067","title":"BNK Banking Corporation Swings to Loss as Revenue Declines and Dividends Remain Suspended","url":"https://stock-news.laohu8.com/highlight/detail?id=2662233067","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662233067?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:08","pubTimestamp":1787785695,"startTime":"0","endTime":"0","summary":"BNK Banking Corporation Limited ( ($AU:BBC) ) has shared an update. BNK Banking Corporation Limited reported a significant deterioration in financi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-swings-to-loss-as-revenue-declines-and-dividends-remain-suspended?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-swings-to-loss-as-revenue-declines-and-dividends-remain-suspended?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194965158","title":"Glacial Melt Swells Rivers, Himalayan Floods Trigger Landslide on China-Nepal Border","url":"https://stock-news.laohu8.com/highlight/detail?id=1194965158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194965158?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:50","pubTimestamp":1787737854,"startTime":"0","endTime":"0","summary":"A flash flood, attributed to a sudden surge in river levels from melting snow, has wreaked havoc in Nepal's Rasuwa district, situated north of the capital Kathmandu and bordering China's Tibet region...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795913","title":"Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795913","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795913?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:52","pubTimestamp":1787730745,"startTime":"0","endTime":"0","summary":"Sosei Group ( ($JP:4565) ) has provided an update. Nxera Pharma’s partner Neurocrine Biosciences has secured FDA IND acceptance for a Phase 2 trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","PSIL","BBC","IND","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107462297","title":"Global Average Sea Surface Temperature Reaches Unprecedented High, Potentially Warmest Since the Last Interglacial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=1107462297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107462297?lang=en_us&edition=fundamental","pubTime":"2026-08-25 11:30","pubTimestamp":1787628645,"startTime":"0","endTime":"0","summary":"Multiple international media outlets reported on the 24th that data from the EU's Copernicus Climate Change Service revealed the average sea surface temperature in non-polar regions hit 21.1°C on...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206573","title":"Savara  announces presentations of Results from Phase 3 trial of Molgramostim","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206573","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206573?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602218,"startTime":"0","endTime":"0","summary":"Savara (SVRA) announced the acceptance of one oral presentation and two poster presentations on data from the Phase 3 IMPALA-2 clinical trial at th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","NVIB","SVRA","HYLG","MEDX","PSIL","GDOC","BK4139","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729270","title":"Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729270?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589063,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. is moving ahead with MARITIME-2-EXTENSION, a Phase 3 trial that t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","TBXU","BBC","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4588","IE00B2B36J28.USD","LU1571399168.USD","BK4139","AMGN","LU2468319806.SGD","LU0868494617.USD","BK4566","LU1061106388.HKD","LU0058720904.USD","IBB","BK4585","LU0320765992.SGD","PSIL","BIB","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","IBBQ","IE0002141913.USD","PJP","BK4533","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4599","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","PBE","SG9999001440.SGD","LU0109394709.USD","LU2242646821.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4534","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294871","title":"Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294871?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330033,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen Inc. has launched a Phase 2 trial testing felzartamab in adults wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogen-expands-autoimmune-pipeline-with-new-graves-disease-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","BK4139","BK4585","BK4588","LU0889565916.HKD","LU0109394709.USD","PSIL","LU0320765992.SGD","BIIB","BK4532","PBE","BK4533","BMED","LU0234570918.USD","BBC","IE00B894F039.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294820","title":"AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294820","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294820?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:30","pubTimestamp":1787329825,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s long-term Phase 2 trial NCT05443724, titled “A 52-week, Phase 2, Open-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRUH","PSIL","LU0310799852.SGD","LU1093756168.USD","LU0158827948.USD","SG9999003800.SGD","ISBC","LU0432979614.USD","IYH","IE0004445239.USD","LU1929549753.HKD","LU1989772840.SGD","AGNG","LU1244550494.USD","XLV","FHLC","BK4588","IE000F7OJYX1.SGD","IXJ","LU0234570918.USD","LU0861579265.USD","IE00B19Z3B42.SGD","BK4550","LU0689626769.HKD","MEDX","PPH","LU0795875086.SGD","ABBV","IE00BJT1NW94.SGD","LU1267930490.SGD","PJP","LU2023251221.USD","FTXH","SG9999001440.SGD","VHT","LU1551013342.USD","BK4534","LU1003077747.HKD","LU1934455863.HKD","LU2237443895.HKD","LU0943347566.SGD","RXL","JDOC","LU0708994859.HKD","IE00B4R5TH58.HKD","GLAM","LU0029864427.USD","LU0256863811.USD","BBC","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661975236","title":"Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY","url":"https://stock-news.laohu8.com/highlight/detail?id=2661975236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661975236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243423,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Study Overview: Bayer has updated results from a terminated Phase 2 trial of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-adempas-trial-update-what-a-terminated-heart-lung-study-means-for-bayry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-adempas-trial-update-what-a-terminated-heart-lung-study-means-for-bayry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PSIL","BBC","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233036","title":"TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233036?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:18","pubTimestamp":1787239108,"startTime":"0","endTime":"0","summary":"An announcement from Evgen Pharma ( ($GB:TCF) ) is now available. TheraCryf plc has announced a proposed £1.05 million equity raise via a placing a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theracryf-raises-1-05m-to-advance-addiction-drug-towards-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theracryf-raises-1-05m-to-advance-addiction-drug-towards-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":144,"code":"91000000","status":"200"}]}}